Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ABGI
3776
DELISTED
ABG Acquisition Corp. I
ABGI
| $4.79M | ﹤0.01% |
489,166
-1,041
| -0.2% | -$10.2K |
|
3777
CALL
Keurig Dr Pepper
KDP
$42.8B
| $4.79M | ﹤0.01% |
135,300
+69,200
| +105% | +$2.51M |
|
|
HHLA
3778
DELISTED
HH&L Acquisition Co.
HHLA
| $4.79M | ﹤0.01% |
487,248
-57
| -0% | -$559 |
|
3779
CALL
Howmet Aerospace
HWM
$115B
| $4.78M | ﹤0.01% |
152,100
-1,900
| -1% | -$65.1K |
|
3780
CALL
iShares Russell 3000 ETF
IWV
$20.5B
| $4.78M | ﹤0.01% |
22,000
+8,600
| +64% | +$2.04M |
|
3781
PUT
Aecom
ACM
$8.12B
| $4.78M | ﹤0.01% |
73,300
+30,800
| +72% | +$2.15M |
|
|
VSXY
3782
CALL
Victoria's Secret
VSXY
$7.08B
| $4.78M | ﹤0.01% |
170,769
+99,164
| +138% | +$4.29M |
|
3783
CALL
Gogo Inc
GOGO
$383M
| $4.77M | ﹤0.01% |
294,900
+2,800
| +1% | +$53.3K |
|
3784
CALL
Matsons
MATX
$6.5B
| $4.77M | ﹤0.01% |
65,500
+18,200
| +38% | +$1.56M |
|
3785
NatWest
NWG
$75.9B
| $4.77M | ﹤0.01% |
813,363
-607,388
| -43% | -$3.64M |
|
3786
PUT
LKQ Corp
LKQ
$6.43B
| $4.77M | ﹤0.01% |
97,200
-7,800
| -7% | -$384K |
|
3787
CALL
Dover
DOV
$27.9B
| $4.77M | ﹤0.01% |
39,300
+3,900
| +11% | +$527K |
|
3788
CALL
Sonos
SONO
$1.93B
| $4.76M | ﹤0.01% |
264,100
-170,900
| -39% | -$3.83M |
|
3789
CALL
Delek US
DK
$4.01B
| $4.76M | ﹤0.01% |
184,200
+129,400
| +236% | +$3.49M |
|
3790
PUT
Sarepta Therapeutics
SRPT
$1.91B
| $4.76M | ﹤0.01% |
63,500
-19,100
| -23% | -$1.41M |
|
3791
Federal Realty Investment Trust
FRT
$10.3B
| $4.76M | ﹤0.01% |
49,686
-462,449
| -90% | -$51.9M |
|
3792
PUT
Sanofi
SNY
$105B
| $4.75M | ﹤0.01% |
95,000
+45,000
| +90% | +$2.39M |
|
3793
CALL
AllianceBernstein
AB
$3.41B
| $4.75M | ﹤0.01% |
114,200
+52,100
| +84% | +$2.19M |
|
3794
CALL
Green Plains
GPRE
$1.09B
| $4.75M | ﹤0.01% |
174,700
+89,500
| +105% | +$2.8M |
|
3795
Rush Enterprises Class A
RUSHA
$9.6B
| $4.75M | ﹤0.01% |
147,753
+68,947
| +87% | +$2.3M |
|
|
CSTA
3796
DELISTED
Constellation Acquisition Corp I
CSTA
| $4.74M | ﹤0.01% |
482,650
-2,124,874
| -81% | -$20.9M |
|
3797
Invesco
IVZ
$14.4B
| $4.74M | ﹤0.01% |
294,087
+170,922
| +139% | +$3.23M |
|
3798
CALL
ProShares Short VIX Short-Term Futures ETF
SVXY
$235M
| $4.74M | ﹤0.01% |
196,600
-386,800
| -66% | -$9.66M |
|
3799
Domo
DOMO
$184M
| $4.74M | ﹤0.01% |
170,454
+143,891
| +542% | +$5.28M |
|
3800
Cullinan Oncology
CGEM
$1.31B
| $4.74M | ﹤0.01% |
369,470
+229,785
| +165% | +$2.61M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.